Literature DB >> 9846034

Treatment of depression in HIV-infected patients.

C L Cazzullo1, E Bessone, P Bertrando, L Pedrazzoli, M Cusini.   

Abstract

BACKGROUND: Pharmacological treatment of depression in HIV-infected patients has been found to be effective. This study assessed the efficacy and feasibility of treatment with fluoxetine and the best method of administering the drug to patients with HIV infection.
METHODS: Sixteen seropositive and 16 seronegative patients, equally matched for age and sex, who had Hamilton Rating Scale for Depression scores of at least 16 and who received at least 20 mg/d of fluoxetine for 8 weeks were studied.
RESULTS: Depression was alleviated in both groups. However, improvement in the seropositive patients occurred later.
INTERPRETATION: The results confirm the effectiveness of fluoxetine in treating depression in people with HIV infection. The lack of adverse effects makes this treatment particularly suitable, especially because seronegative people take longer to respond to treatment.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9846034      PMCID: PMC1188957     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  13 in total

1.  Mini-compendium of rating scales for states of anxiety depression mania schizophrenia with corresponding DSM-III syndromes.

Authors:  P Bech; M Kastrup; O J Rafaelsen
Journal:  Acta Psychiatr Scand Suppl       Date:  1986

2.  Psychopharmacology in HIV-positive patients: research perspectives.

Authors:  B Vitiello; E S Stover
Journal:  Psychopharmacol Bull       Date:  1996

3.  Effects of sertraline on mood and immune status in patients with major depression and HIV illness: an open trial.

Authors:  J G Rabkin; G Wagner; R Rabkin
Journal:  J Clin Psychiatry       Date:  1994-10       Impact factor: 4.384

Review 4.  Psychopharmacotherapy of psychiatric syndromes in asymptomatic and symptomatic HIV infection.

Authors:  F Fernandez; J K Levy
Journal:  Psychiatr Med       Date:  1991

5.  WHO Neuropsychiatric AIDS study, cross-sectional phase I. Study design and psychiatric findings.

Authors:  M Maj; R Janssen; F Starace; M Zaudig; P Satz; B Sughondhabirom; M A Luabeya; R Riedel; D Ndetei; H M Calil
Journal:  Arch Gen Psychiatry       Date:  1994-01

6.  WHO Neuropsychiatric AIDS study, cross-sectional phase II. Neuropsychological and neurological findings.

Authors:  M Maj; P Satz; R Janssen; M Zaudig; F Starace; L D'Elia; B Sughondhabirom; M Mussa; D Naber; D Ndetei
Journal:  Arch Gen Psychiatry       Date:  1994-01

7.  Fluoxetine treatment of depressed patients with HIV infection.

Authors:  F K Judd; A M Mijch; A Cockram
Journal:  Aust N Z J Psychiatry       Date:  1995-09       Impact factor: 5.744

Review 8.  Psychopharmacology in HIV spectrum disorders.

Authors:  F Fernandez; J K Levy
Journal:  Psychiatr Clin North Am       Date:  1994-03

9.  Effects of fluoxetine on mood and immune status in depressed patients with HIV illness.

Authors:  J G Rabkin; R Rabkin; G Wagner
Journal:  J Clin Psychiatry       Date:  1994-03       Impact factor: 4.384

10.  Effect of imipramine on mood and enumerative measures of immune status in depressed patients with HIV illness.

Authors:  J G Rabkin; R Rabkin; W Harrison; G Wagner
Journal:  Am J Psychiatry       Date:  1994-04       Impact factor: 18.112

View more
  4 in total

Review 1.  Drug treatment of depression in HIV-positive patients : safety considerations.

Authors:  Andrew A Pieper; Glenn J Treisman
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 2.  Fluoxetine: a review of its therapeutic potential in the treatment of depression associated with physical illness.

Authors:  S M Cheer; K L Goa
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Antidepressant treatment and health services utilization among HIV-infected medicaid patients diagnosed with depression.

Authors:  U Sambamoorthi; J Walkup; M Olfson; S Crystal
Journal:  J Gen Intern Med       Date:  2000-05       Impact factor: 5.128

Review 4.  Pharmacologic treatment of mood disorders in acquired immune deficiency syndrome (AIDS).

Authors:  Jordan Klesmer; Ruxandra Badescu
Journal:  Curr Psychiatry Rep       Date:  2002-06       Impact factor: 8.081

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.